Literature DB >> 32445534

Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Pei-Suen Tsou1, Amr H Sawalha2,3,4.   

Abstract

The glycoprotein nonmetastatic melanoma protein B (GPNMB, also known as osteoactivin) is highly expressed in many cell types and regulates the homeostasis in various tissues. In different physiological contexts, it functions as a melanosome-associated protein, membrane-bound surface receptor, soluble ligand, or adhesion molecule. Therefore, GPNMB is involved in cell differentiation, migration, inflammation, metabolism, and neuroprotection. Because of its various involvement in different physiological conditions, GPNMB has been implicated in many diseases, including cancer, neurological disorders, and more recently immune-mediated diseases. This review summarizes the regulation and function of GPNMB in normal physiology, and discusses the involvement of GPNMB in disease conditions with a particular focus on its potential role and therapeutic implications in autoimmunity.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  GPNMB; autoimmunity; lupus; osteoactivin; vasculitis

Mesh:

Substances:

Year:  2020        PMID: 32445534      PMCID: PMC7501235          DOI: 10.1096/fj.202000651

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  114 in total

1.  Glycoprotein Nonmelanoma Clone B Regulates the Crosstalk between Macrophages and Mesenchymal Stem Cells toward Wound Repair.

Authors:  Bing Yu; Talib Alboslemy; Fayez Safadi; Min-Ho Kim
Journal:  J Invest Dermatol       Date:  2017-09-09       Impact factor: 8.551

2.  Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.

Authors:  Nagat Frara; Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Vanessa R Yingling; Thomas A Owen; Steven N Popoff; Mary F Barbe; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2016-01       Impact factor: 6.384

3.  Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts.

Authors:  F F Safadi; J Xu; S L Smock; M C Rico; T A Owen; S N Popoff
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

4.  nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts.

Authors:  M A Weterman; N Ajubi; I M van Dinter; W G Degen; G N van Muijen; D J Ruitter; H P Bloemers
Journal:  Int J Cancer       Date:  1995-01-03       Impact factor: 7.396

5.  Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts.

Authors:  Maneet Singh; Fabiola E Del Carpio-Cano; M Alexandra Monroy; Steven N Popoff; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

6.  Effects of GPNMB on proliferation and odontoblastic differentiation of human dental pulp cells.

Authors:  Yu-Liang Wang; Ye-Jia Hu; Feng-He Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.

Authors:  Samir M Abdelmagid; Mary F Barbe; Mario C Rico; Sibel Salihoglu; Israel Arango-Hisijara; Abdul Hafez Selim; Michael G Anderson; Thomas A Owen; Steven N Popoff; Fayez F Safadi
Journal:  Exp Cell Res       Date:  2008-03-10       Impact factor: 3.905

8.  Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.

Authors:  Seung-Beom Hong; HyoungBin Oh; Vladimir A Valera; Masaya Baba; Laura S Schmidt; W Marston Linehan
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

9.  Endothelin-1 enhances the melanogenesis via MITF-GPNMB pathway.

Authors:  Ping Zhang; Wei Liu; Xiaoying Yuan; Dongguang Li; Weijie Gu; Tianwen Gao
Journal:  BMB Rep       Date:  2013-07       Impact factor: 4.778

10.  Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells.

Authors:  Moses O Oyewumi; Dharani Manickavasagam; Kimberly Novak; Daniel Wehrung; Nikola Paulic; Fouad M Moussa; Gregory R Sondag; Fayez F Safadi
Journal:  Oncotarget       Date:  2016-03-22
View more
  7 in total

Review 1.  GPNMB: a potent inducer of immunosuppression in cancer.

Authors:  Anna-Maria Lazaratos; Matthew G Annis; Peter M Siegel
Journal:  Oncogene       Date:  2022-09-01       Impact factor: 8.756

Review 2.  Considerations for the Nonclinical Safety Evaluation of Antibody-Drug Conjugates.

Authors:  J Edward Fisher
Journal:  Antibodies (Basel)       Date:  2021-04-19

3.  Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity.

Authors:  Preethi Cherian; Irina Al-Khairi; Mohammad Jamal; Suleiman Al-Sabah; Hamad Ali; Carol Dsouza; Eman Alshawaf; Waleed Al-Ali; Ghanim Al-Khaledi; Fahd Al-Mulla; Mohamed Abu-Farha; Jehad Abubaker
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-29       Impact factor: 5.555

4.  Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis.

Authors:  Pamela J Palisoc; Leah Vaikutis; Mikel Gurrea-Rubio; Ellen N Model; Morgan M O'mara; Sarah Ory; Sirapa Vichaikul; Dinesh Khanna; Pei-Suen Tsou; Amr H Sawalha
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

5.  Analysis of Hepatic Lipid Metabolism and Immune Function During the Development of Collagen-Induced Arthritis.

Authors:  Yingjie Shi; Jun Shu; Zhangchi Ning; Dancai Fan; Haiyang Shu; Hanxiao Zhao; Li Li; Ning Zhao; Cheng Lu; Aiping Lu; Xiaojuan He
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

6.  Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.

Authors:  Jorge L Rodriguez-Gil; Laura L Baxter; Dawn E Watkins-Chow; Nicholas L Johnson; Cristin D Davidson; Steven R Carlson; Arturo A Incao; Kerri L Wallom; Nicole Y Farhat; Frances M Platt; Ryan K Dale; Forbes D Porter; William J Pavan
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 5.121

7.  Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.

Authors:  Meixiang Huang; Erica Modeste; Eric Dammer; Paola Merino; Georgia Taylor; Duc M Duong; Qiudong Deng; Christopher J Holler; Marla Gearing; Dennis Dickson; Nicholas T Seyfried; Thomas Kukar
Journal:  Acta Neuropathol Commun       Date:  2020-10-07       Impact factor: 7.578

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.